Patent for EntreMed's cell electroporation:
This article was originally published in Clinica
EntreMed has obtained a US patent on its 'electroporation chamber', a method of permeating tissue cells with therapeutic substances ex vivo. Cincinnati University researchers are using the device to insert the oxygenation-enhancing drug inositol hexaphosphate (IHP) into red blood cells. They plan clinical trials in which the IHP-treated cells are infused back into patients as a treatment for angina and other conditions due to inadequate tissue oxygenation.